B2B

Spacer

We are your partner!


A growing market

Sophisticated injection systems for self administration, in particular injection pens, are well established. Their use continues to expand for the treatment of diabetes, growth disorders, infertility as well as many other indications. The use of dedicated devices not only improves patient care, but can also help to differentiate the particular drug therapy from the competition. The demand for new injection devices continues to grow as injectable biotech drugs are developed in existing and new therapeutic areas. Sophisticated injection devices can improve patient compliance and the success of the therapy. Some drugs require frequent, variable dose injections while others require less frequent, fixed dose injections. The larger volume, fixed dose injection of drugs, particularly for the treatment of autoimmune diseases, are increasing the demand for sophisticated auto-injection devices.

A changing market

Today, patient groups and healthcare specialists are generally well informed and demand more effective drugs and delivery systems for injection therapies. Pharmaceutical and biotech companies have responded to these increased demands and are using more convenient drug reservoirs – cartridges and pre-filled syringes instead of vials – which are compatible for use with injection pens and auto-injectors. Allowing patients to self-inject and reducing their dependence on healthcare specialists increases compliance and helps to reduce healthcare spending.

Benefits for the patient

  • Easy and intuitive to use, convenient and discrete devices enhance overall injection comfort
  • Safe, reliable and accurate devices
  • Reduced pain – fine needles, controlled injection speed
  • Needle covers to counter needle phobia and potentially also protect from accidental needle stick injuries
  • Lifestyle flexibility – less dependence on healthcare professionals


Benefits for the pharmaceutical company

  • Improved patient compliance and thus more successful therapy outcome
  • Increased patient identification with your drug
  • Differentiation from competitors
  • Positive impact on market share


To select the appropriate device technology, essential questions are:

  • Is the drug/therapy suitable for self injection?
  • What are the specific patient needs for this therapy?
  • Is the drug reservoir already defined?
  • What are the injection frequency and dosing specifications?


Involve Ypsomed and the experience we bring early in your development project. Obtaining the answers to these questions in the earliest possible time is a crucial step towards a timely launch of your dedicated injection device.






© Copyright Ypsomed 2003- All rights reserved

10. November 2008

Pharmapack Symposium - Tokyo, Japan >>>more

14. November 2008

Pharmapack Symposium - Bejing, China >>>more

17. November 2008

Pharmapack Symposium - Mumbai, Indien >>>more